Alpha Diagnostic International, Inc. Anti-Human Liver-expressed antimicrobial peptide 2 (LEAP2) IgG #1 (aff pure) LEAP22-A

Anti-Human Liver-expressed antimicrobial peptide 2 (LEAP2) IgG #1 (aff pure) General Information From human blood ultrafiltrate, a novel gene-encoded, cysteine-rich, and cationic peptide termed as liver-expressed antimicrobial peptide 2 (LEAP-2) together with several circulating forms of LEAP-2 differing in their amino-terminal length were identified SugApplications Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the SugSecAntibodies http://4adi.com/comm erce/ccc2480-seconda ry-antibodies-rabbit .htm SpeciesReactivity Human SugNegativeControl Non-immune Rabbit IgG Cat# 20009-1 Form Affinity purified IgG SugPositiveControl Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid Antigen 20-aa peptide of Human LEAP-2 (Protein accession # Q969E1 ; ref. 1); designated as LEAP22-P control/blocking peptide conjugated to KLH; epitope location ~ C-terminus SpCrossreactivity Human LEAP22-P peptide sequence is 100% conserved in mouse and rat. Antibody cross-reactivity in various species is not known For research use only, not for diagnostic or therapeutic use.